Category: Portfolio Updates

RED HOT CHILI™ MUMAK

RED HOT CHILI™ MUMAK of the Week: Johnson & Johnson – Breakout Drawing Closer?

Johnson & Johnson shows operational strength and a constructive chart picture. The resistance at $273–274 now comes into focus.
Next Update
RED HOT CHILI™ MUMAK

RED HOT CHILI™ MUMAK of the Week: MercadoLibre – New Momentum Ahead of Critical Resistance

MercadoLibre receives the RED HOT CHILI™️ MUMAK of the week. Strong growth in e-commerce and fintech meets a significantly improved
Next Update
RED HOT CHILI™ MUMAK

RED HOT CHILI MUMAK of the Week: Johnson & Johnson – Technical Chart Picture Brightens Significantly

Following strong quarterly figures, a raised annual guidance, and a further improvement in the chart setup, Johnson & Johnson receives
Next Update
RED HOT CHILI™ MUMAK

RED HOT CHILI mumak of the Week: SpaceX – Technical Chart Picture Brightens Significantly

Following the significant recovery from the August low and a noticeable improvement in the short-term chart setup, SpaceX receives the
Next Update
MUMAK SpotLight

MUMAK SpotLight of the Week: Apple and Amazon Quarterly Review

Apple and Amazon make a statement – strong quarterly results with differing market reactions
Next Update
Weekly Update

Weekly Market Overview – May 4–10, 2026

Weekly Market Overview (May 4–10, 2026): Markets Seek Stability: Energy Remains Volatile as Tesla and Apple Are Added to the
Next Update
Weekly Update

Weekly Market Overview – April 27 – May 3, 2026

Weekly Market Overview (April 27 - May 3, 2026): The market overview shows stable yet sensitive markets. Oil prices remain
Next Update
Tesla
Company Update

Tesla – Q2 2026 Earnings Update

Tesla delivered record revenue and strong vehicle deliveries in Q2 2026. However, heavy investment in AI and robotics weighed on
Next Update
Bayer
Company Update

Bayer – Q2 2026 Earnings Update

Bayer increases revenue and operating earnings in Q2 2026 and confirms its full-year targets despite legal risks.
Next Update
Johnson & Johnson
Company Update

Johnson & Johnson – Q2 2026 Earnings Update

Johnson & Johnson impresses with strong Q2 2026 figures, significantly increasing revenue and free cash flow while raising its guidance
Next Update
TKMS
Company Update

TKMS – Q3 2026 Earnings Update

TKMS increases revenue by 19% and raises guidance. The high order backlog supports long-term growth prospects.
Next Update
Eli Lilly
Company Update

Eli Lilly – Q2 2026 Earnings Update

Eli Lilly grows rapidly in the second quarter of 2026: Revenue rises 48 percent, Mounjaro and Zepbound skyrocket, full-year guidance
Next Update